{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:06:04Z","timestamp":1780495564309,"version":"3.54.1"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.2169\/internalmedicine.0434-22","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T22:13:23Z","timestamp":1663020803000},"page":"1279-1285","source":"Crossref","is-referenced-by-count":5,"title":["Severe Enteritis after Cyclophosphamide Administration in a Patient with Microscopic Polyangiitis: A Case Report and Literature Review"],"prefix":"10.2169","volume":"62","author":[{"given":"Shuhei","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Temmoku","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Yashiro-Furuya","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Gunji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dan D, Fischer R, Adler S, F\u00f6rger F, Villiger PM. Cyclophosphamide: as bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases. Swiss Med Wkly 144: w14030, 2014.","DOI":"10.4414\/smw.2014.14030"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Li J, Dai G, Zhang Z. General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade - a single-center retrospective study. Clin Rheumatol 34: 273-278, 2015.","DOI":"10.1007\/s10067-014-2748-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yang LS, Cameron K, Papaluca T, et al. Cyclophosphamide-associated enteritis: a rare association with severe enteritis. World J Gastroenterol 22: 8844-8848, 2016.","DOI":"10.3748\/wjg.v22.i39.8844"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sato H, Shirai T, Fujii H, Ishii T, Harigae H. Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: a case report. World J Gastroenterol 27: 2657-2663, 2021.","DOI":"10.3748\/wjg.v27.i20.2657"},{"key":"5","first-page":"275","volume":"49","author":"O Bujakowska","year":"2011","unstructured":"5. Bujakowska O, Kur-Zalewska J, T\u0142ustochowicz W. Hemorrhagic colitis as a complication of treatment with cyclophosphamide. Reumatologia 49: 275-278, 2011.","journal-title":"Reumatologia\/Rheumatology","ISSN":"https:\/\/id.crossref.org\/issn\/0034-6233","issn-type":"print"},{"key":"6","first-page":"2137","volume":"59","author":"TH Seo","year":"2012","unstructured":"6. Seo TH, Kim JH, Ko SY, et al. Cytomegalovirus colitis in immunocompetent patients: a clinical and endoscopic study. Hepatogastroenterology 59: 2137-2141, 2012.","journal-title":"Hepatogastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0172-6390","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Liu T, Wu Y, Wang L, et al. A more robust gut microbiota in calorie-restricted mice is associated with attenuated intestinal injury caused by the chemotherapy drug cyclophosphamide. mBio 10: e02903-e02918, 2019.","DOI":"10.1128\/mBio.02903-18"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Emmenegger U, Man S, Shaked Y, et al. A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens. Cancer Res 64: 3994-4000, 2004.","DOI":"10.1158\/0008-5472.CAN-04-0580"},{"key":"9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2407-13-56","volume":"13","author":"F Russo","year":"2013","unstructured":"9. Russo F, Linsalata M, Clemente C, et al. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer 13: 56, 2013.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. McQuade RM, Al Thaalibi M, Nurgali K. Impact of chemotherapy-induced enteric nervous system toxicity on gastrointestinal mucositis. Curr Opin Support Palliat Care 14: 293-300, 2020.","DOI":"10.1097\/SPC.0000000000000515"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kuchay RA. A review of complementary therapies for chemotherapy induced gastrointestinal mucositis. Drug Discov Ther 10: 292-299, 2017.","DOI":"10.5582\/ddt.2016.01059"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342: 971-976, 2013.","DOI":"10.1126\/science.1240537"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ekhart C, Kerst JM, Rodenhuis S, Beijnen JH, Huitema AD. Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency. Cancer Chemother Pharmacol 63: 375-379, 2009.","DOI":"10.1007\/s00280-008-0757-z"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency. Kidney Int 61: 1495-1501, 2002.","DOI":"10.1046\/j.1523-1755.2002.00279.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/9\/62_0434-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T03:25:54Z","timestamp":1683343554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/9\/62_0434-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0434-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"article-number":"0434-22"}}